这是一篇来自已证抗体库的有关人类 CD247的综述,是根据150篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合CD247 抗体。
CD247 同义词: CD3-ZETA; CD3H; CD3Q; CD3Z; IMD25; T3Z; TCRZ

赛默飞世尔
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s1a
赛默飞世尔 CD247抗体(eBioscience, 17-0036-42)被用于被用于流式细胞仪在人类样本上 (图 s1a). BMC Cancer (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 3f, 3g
赛默飞世尔 CD247抗体(Invitrogen, SK7)被用于被用于流式细胞仪在人类样本上 (图 3f, 3g). Brain Pathol (2020) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2 ug/ml; 图 4a
赛默飞世尔 CD247抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上浓度为2 ug/ml (图 4a). Diagn Pathol (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 猕猴; 1:200; 图 3g
赛默飞世尔 CD247抗体(Invitrogen, 47-0037-41)被用于被用于流式细胞仪在猕猴样本上浓度为1:200 (图 3g). Nature (2019) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 1:200; 图 2s1b
赛默飞世尔 CD247抗体(eBioscience, 45-0037-71)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 2s1b). elife (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Arthritis Res Ther (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD247抗体(eBioscience, 45-0036)被用于被用于流式细胞仪在人类样本上 (图 1a). Cell (2019) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s2a
赛默飞世尔 CD247抗体(生活技术, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s2a). Nat Med (2019) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 s18b
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 s18b). Science (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3i
赛默飞世尔 CD247抗体(eBiosciences, 13-0037-82)被用于被用于流式细胞仪在人类样本上 (图 s3i). Cell (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 s4a
赛默飞世尔 CD247抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 s4a). Sci Immunol (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1b). J Clin Invest (2018) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2c
赛默飞世尔 CD247抗体(ebioscience, 16-0037)被用于被用于流式细胞仪在人类样本上 (图 2c). Cell Death Dis (2017) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 图 s1
赛默飞世尔 CD247抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 s1). Eur J Immunol (2018) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD247抗体(eBioscience, 13-0038-82)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD247抗体(eBioscience, 11-0037-42)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 6d
赛默飞世尔 CD247抗体(ebioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 6d). PLoS ONE (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 1:200; 图 4a
赛默飞世尔 CD247抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上浓度为1:200 (图 4a). Front Immunol (2017) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 流式细胞仪; 人类; 图 1e
赛默飞世尔 CD247抗体(Invitrogen, MHCD0331)被用于被用于流式细胞仪在人类样本上 (图 1e). J Clin Invest (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 表 1
赛默飞世尔 CD247抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (表 1). Cell (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD247抗体(eBioscience, 48-0038-42)被用于被用于流式细胞仪在人类样本上 (图 3a). Oncoimmunology (2017) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 30 ng/ml; 图 s9
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为30 ng/ml (图 s9). Nature (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3e
赛默飞世尔 CD247抗体(Thermo Fisher Scientific, 48-0038)被用于被用于流式细胞仪在人类样本上 (图 3e). Cell Res (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD247抗体(Thermo Fisher Scientific, 11-0039)被用于被用于流式细胞仪在人类样本上 (图 3a). Cell Res (2017) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4b
赛默飞世尔 CD247抗体(eBioscience, 11-0038)被用于被用于流式细胞仪在人类样本上 (图 4b). Cell (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 3a
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 3a). J Immunol (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD247抗体(eBioscience, OKT-3)被用于被用于流式细胞仪在人类样本上 (图 2a). Oncoimmunology (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). Med Princ Pract (2017) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1). J Clin Invest (2017) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(ebioscience, HIT3a)被用于被用于流式细胞仪在人类样本上. Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(OKT3)
  • 免疫细胞化学; 人类; 表 1
赛默飞世尔 CD247抗体(eBioscience, 16-0037-81)被用于被用于免疫细胞化学在人类样本上 (表 1). J Vis Exp (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2c
赛默飞世尔 CD247抗体(eBiosciences, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2c). PLoS Pathog (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于. Leukemia (2017) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD247抗体(eBiosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1b). J Immunol (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD247抗体(Invitrogen, UCHT1)被用于. AIDS Res Hum Retroviruses (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2.5 ug/ml; 图 7d
赛默飞世尔 CD247抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ug/ml (图 7d). Mol Biol Cell (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 6a
赛默飞世尔 CD247抗体(eBiosciences, 16-0037)被用于被用于抑制或激活实验在人类样本上 (图 6a). Mol Biol Cell (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD247抗体(eBioscience, 16-0037)被用于被用于抑制或激活实验在人类样本上 (图 1). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(Invitrogen, MHCD0331)被用于被用于流式细胞仪在人类样本上. Cell Death Dis (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. elife (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 1a
赛默飞世尔 CD247抗体(eBiosciences, SK7)被用于被用于流式细胞仪在人类样本上 (图 1a). J Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 s3a
赛默飞世尔 CD247抗体(eBiosciences, UCHT1)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 s3a). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD247抗体(Invitrogen, UCHT1)被用于. PLoS ONE (2016) ncbi
小鼠 单克隆(UCHT1)
  • 免疫组化; 人类; 1:200; 图 5d
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于免疫组化在人类样本上浓度为1:200 (图 5d). Mol Cancer Res (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 1). Oncotarget (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 图 S1
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (图 S1). Sci Rep (2016) ncbi
小鼠 单克隆(UCHT1)
  • mass cytometry; 人类; 表 1, 2
赛默飞世尔 CD247抗体(生活技术, UCHT1)被用于被用于mass cytometry在人类样本上 (表 1, 2). Methods Mol Biol (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 s2a
  • 免疫组化-石蜡切片; 人类; 图 4b
赛默飞世尔 CD247抗体(eBioscience, EB16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 s2a) 和 被用于免疫组化-石蜡切片在人类样本上 (图 4b). J Immunother Cancer (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, 48-0038-42)被用于被用于流式细胞仪在人类样本上. Oncoimmunology (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 8
赛默飞世尔 CD247抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 8). J Exp Med (2016) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD247抗体(eBioscience, OKT-3)被用于被用于流式细胞仪在人类样本上 (图 4). Sci Rep (2016) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于. Immunol Res (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 2
赛默飞世尔 CD247抗体(eBioscence, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 2). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 5). PLoS Pathog (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. Eur J Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 3
赛默飞世尔 CD247抗体(Tonbo, 25-0038)被用于被用于流式细胞仪在人类样本上 (图 3). Nat Commun (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 7
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 7). Eur J Immunol (2016) ncbi
小鼠 单克隆(HIT3a)
  • 酶联免疫吸附测定; 人类; 图 2
赛默飞世尔 CD247抗体(eBioscience, 16?C0039)被用于被用于酶联免疫吸附测定在人类样本上 (图 2). PLoS ONE (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s1a
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s1a). J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 小鼠
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在小鼠样本上. Nat Chem Biol (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 e3d
赛默飞世尔 CD247抗体(eBioscience, (HIT3A)被用于被用于流式细胞仪在人类样本上 (图 e3d). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 e3d
赛默飞世尔 CD247抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 e3d). J Allergy Clin Immunol (2016) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 1
赛默飞世尔 CD247抗体(eBioscience, 16-0037-85)被用于被用于抑制或激活实验在人类样本上 (图 1). MAbs (2016) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBiosciences, SK7)被用于被用于流式细胞仪在人类样本上. Respir Res (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 1 ug/ml; 图 6c
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为1 ug/ml (图 6c). Nat Immunol (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 s5
赛默飞世尔 CD247抗体(eBiosciences, 16-0037)被用于被用于抑制或激活实验在人类样本上 (图 s5). Nat Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 2a
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 2a). Kidney Int (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 4). J Neuroinflammation (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1b
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1b). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD247抗体(eBioscience, HIT3A)被用于被用于流式细胞仪在人类样本上 (图 s3). J Exp Med (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 s3
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 s3). J Exp Med (2015) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, 48-0037-42)被用于被用于流式细胞仪在人类样本上. Blood Cancer J (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 10 ng/ml; 图 1
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为10 ng/ml (图 1). J Chin Med Assoc (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 图 6
赛默飞世尔 CD247抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 6). Bone Marrow Transplant (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 5 ug/ml
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为5 ug/ml. J Virol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, 48-0038)被用于被用于流式细胞仪在人类样本上. Cancer Res (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (表 1). J Immunol (2015) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 表 s1
赛默飞世尔 CD247抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (表 s1). Proc Natl Acad Sci U S A (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 图 3
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上 (图 3). Cancer Immunol Res (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. J Cell Biol (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 0.5 ug/ml
赛默飞世尔 CD247抗体(eBIoscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为0.5 ug/ml. J Biol Chem (2015) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 小鼠; 1:2000
赛默飞世尔 CD247抗体(Invitrogen, S4.1PB)被用于被用于流式细胞仪在小鼠样本上浓度为1:2000. Stem Cell Res (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. J Autoimmun (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. J Allergy Clin Immunol (2015) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 6g
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 6g). Cytometry B Clin Cytom (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(e-Bioscience, SK7)被用于被用于流式细胞仪在人类样本上. Nat Commun (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD247抗体(eBiosciences, UCHT1)被用于被用于流式细胞仪在人类样本上 (表 1). J Gen Virol (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2 ug/ml
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为2 ug/ml. PLoS Negl Trop Dis (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 50 ng/ml
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上浓度为50 ng/ml. J Leukoc Biol (2014) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. Immunobiology (2015) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. Med Microbiol Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Exp Med (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, 45-0037-42)被用于被用于流式细胞仪在人类样本上. Gut Microbes (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. J Infect Dis (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBiosciences, OKT3)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(e-Biosciences, OKT-3)被用于被用于流式细胞仪在人类样本上. J Clin Immunol (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol Res (2014) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(Invitrogen, MHCD0331)被用于被用于流式细胞仪在人类样本上. J Transl Med (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS ONE (2014) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD247抗体(Invitrogen, UCHT1)被用于. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 免疫细胞化学; 人类; 表 1
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于免疫细胞化学在人类样本上 (表 1). Nat Immunol (2014) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, 14-0037-82)被用于被用于流式细胞仪在人类样本上. Clin Cancer Res (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD247抗体(Invitrogen, UCHT1)被用于被用于流式细胞仪在人类样本上 (图 1). Cancer Immunol Immunother (2014) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 3 ug/ml
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为3 ug/ml. J Immunol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(Ebioscience, UCHT1)被用于被用于抑制或激活实验在人类样本上. PLoS ONE (2013) ncbi
小鼠 单克隆(HIT3a)
  • 抑制或激活实验; 人类; 0.5 ug/ml; 图 1
赛默飞世尔 CD247抗体(eBioscience, HIT3a)被用于被用于抑制或激活实验在人类样本上浓度为0.5 ug/ml (图 1). Ann Rheum Dis (2015) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. Clin Exp Immunol (2014) ncbi
小鼠 单克隆(UCHT1, HIB19)
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于. J Infect Dis (2014) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上. Blood (2014) ncbi
小鼠 单克隆(SK7)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, SK7)被用于被用于流式细胞仪在人类样本上. J Hepatol (2014) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, UCHT1)被用于被用于流式细胞仪在人类样本上. Ann Rheum Dis (2014) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(Invitrogen, noca)被用于被用于流式细胞仪在人类样本上. PLoS Pathog (2013) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类; 图 5
赛默飞世尔 CD247抗体(Invitrogen, S4.1)被用于被用于流式细胞仪在人类样本上 (图 5). J Immunol (2012) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBiosciences, UHCT1)被用于被用于流式细胞仪在人类样本上. Blood (2011) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 2.5 ug/ml
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ug/ml. PLoS ONE (2011) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 S2
赛默飞世尔 CD247抗体(eBioscience, 46-0037-42)被用于被用于流式细胞仪在人类样本上 (图 S2). Proc Natl Acad Sci U S A (2012) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 2
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 2). Immunobiology (2011) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 小鼠; 图 3
赛默飞世尔 CD247抗体(Caltag, S4.1)被用于被用于流式细胞仪在小鼠样本上 (图 3). Blood (2010) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD247抗体(eBioscience, UCHT-1)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2010) ncbi
小鼠 单克隆(S4.1)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(Invitrogen, noca)被用于被用于流式细胞仪在人类样本上. J Immunol Methods (2009) ncbi
小鼠 单克隆(UCHT1)
  • 流式细胞仪; 人类; 表 1
赛默飞世尔 CD247抗体(eBioscience, 15-0038)被用于被用于流式细胞仪在人类样本上 (表 1). Med Oncol (2010) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 4
  • 流式细胞仪; 猕猴; 图 4
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上 (图 4) 和 被用于流式细胞仪在猕猴样本上 (图 4). J Virol (2008) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上. J Virol (2007) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类; 0.5 ug/ml
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于抑制或激活实验在人类样本上浓度为0.5 ug/ml. PLoS ONE (2006) ncbi
小鼠 单克隆(HIT3a)
  • 流式细胞仪; 人类; 图 4
赛默飞世尔 CD247抗体(eBioscience, HIT3a)被用于被用于流式细胞仪在人类样本上 (图 4). J Virol (2006) ncbi
小鼠 单克隆(OKT3)
  • 抑制或激活实验; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT-3)被用于被用于抑制或激活实验在人类样本上. J Immunol (2006) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类
赛默飞世尔 CD247抗体(eBioscience, OKT3)被用于被用于流式细胞仪在人类样本上. J Immunol (2006) ncbi
小鼠 单克隆(OKT3)
  • 流式细胞仪; 人类; 图 1
赛默飞世尔 CD247抗体(Caltag, OKT3)被用于被用于流式细胞仪在人类样本上 (图 1). J Immunol (2002) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 免疫沉淀; 人类; 图 3
赛默飞世尔 CD247抗体(noco, noca)被用于被用于免疫沉淀在人类样本上 (图 3). J Biol Chem (1983) ncbi
小鼠 单克隆(S4.1)
  • 免疫沉淀; 人类; 图 3
赛默飞世尔 CD247抗体(noco, noca)被用于被用于免疫沉淀在人类样本上 (图 3). J Biol Chem (1983) ncbi
小鼠 单克隆(S4.1)
  • 免疫印迹; 人类
赛默飞世尔 CD247抗体(noco, noca)被用于被用于免疫印迹在人类样本上. Nature (1986) ncbi
小鼠 单克隆(S4.1 (7D6))
  • 免疫印迹; 人类
赛默飞世尔 CD247抗体(noco, noca)被用于被用于免疫印迹在人类样本上. Nature (1986) ncbi
圣克鲁斯生物技术
小鼠 单克隆(6B10.2)
  • 免疫印迹; 小鼠; 1:1000; 图 6c
圣克鲁斯生物技术 CD247抗体(Santa, sc-1239)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6c). Nat Commun (2018) ncbi
小鼠 单克隆(6B10.2)
  • 免疫印迹; 人类; 图 s7
圣克鲁斯生物技术 CD247抗体(SantaCruz, 6B10.2)被用于被用于免疫印迹在人类样本上 (图 s7). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(C415.9A)
  • 免疫印迹; 人类; 图 s7
圣克鲁斯生物技术 CD247抗体(SantaCruz, C415.9A)被用于被用于免疫印迹在人类样本上 (图 s7). Proc Natl Acad Sci U S A (2017) ncbi
小鼠 单克隆(6B10.2)
  • 免疫组化-石蜡切片; 人类; 1:4000; 图 3
圣克鲁斯生物技术 CD247抗体(Santa Cruz, sc1239)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:4000 (图 3). J Transl Med (2016) ncbi
小鼠 单克隆(6B10.2)
  • 免疫印迹; 人类; 1:1000; 图 1a
圣克鲁斯生物技术 CD247抗体(Santa Cruz Biotechnology, 6B.10)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1a). PLoS ONE (2015) ncbi
小鼠 单克隆(6B10.2)
  • 免疫组化; 人类
圣克鲁斯生物技术 CD247抗体(Santa Cruz Biotechnology, 6B10.2)被用于被用于免疫组化在人类样本上. J Allergy Clin Immunol (2014) ncbi
艾博抗(上海)贸易有限公司
gray dwarf hamster 单克隆(H146-968)
  • 免疫印迹; 人类; 图 2c
艾博抗(上海)贸易有限公司 CD247抗体(Abcam, H136-968)被用于被用于免疫印迹在人类样本上 (图 2c). J Immunol (2018) ncbi
domestic rabbit 单克隆(EP776(2)Y)
  • 免疫印迹; 人类; 图 6d
艾博抗(上海)贸易有限公司 CD247抗体(Epitomics, EP776(2)Y)被用于被用于免疫印迹在人类样本上 (图 6d). Proc Natl Acad Sci U S A (2017) ncbi
domestic rabbit 单克隆(EP776(2)Y)
  • 免疫印迹; 小鼠; 1:1000; 图 8
  • 免疫印迹; 人类; 1:1000; 图 6
艾博抗(上海)贸易有限公司 CD247抗体(Abcam, ab68236)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 8) 和 被用于免疫印迹在人类样本上浓度为1:1000 (图 6). Nat Commun (2016) ncbi
亚诺法生技股份有限公司
小鼠 单克隆(4A12-F6)
  • 其他; 人类; 图 st1
亚诺法生技股份有限公司 CD247抗体(Abnova, 4A12-F6)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
贝克曼库尔特实验系统(苏州)有限公司
小鼠 单克隆(2H2D9)
  • 流式细胞仪; 人类
贝克曼库尔特实验系统(苏州)有限公司 CD247抗体(Beckman Coulter, 2H2D9)被用于被用于流式细胞仪在人类样本上. J Immunol (2015) ncbi
碧迪BD
小鼠 单克隆(K25-407.69)
  • 免疫印迹; 人类; 图 s7b
碧迪BD CD247抗体(BD Biosciences, 558402)被用于被用于免疫印迹在人类样本上 (图 s7b). Science (2017) ncbi
小鼠 单克隆(K25-407.69)
  • 流式细胞仪; 人类; 图 4c
碧迪BD CD247抗体(BD Biosciences, 558489)被用于被用于流式细胞仪在人类样本上 (图 4c). Oncoimmunology (2016) ncbi
小鼠 单克隆(K25-407.69)
  • 免疫细胞化学; 人类; 图 s12
碧迪BD CD247抗体(BD Biosciences, 558402)被用于被用于免疫细胞化学在人类样本上 (图 s12). Mol Biol Cell (2016) ncbi
小鼠 单克隆(K25-407.69)
  • 流式细胞仪; 小鼠; 1:50; 图 7
碧迪BD CD247抗体(BD Biosciences, 558486)被用于被用于流式细胞仪在小鼠样本上浓度为1:50 (图 7). Nat Commun (2016) ncbi
小鼠 单克隆(K25-407.69)
  • 免疫细胞化学; 人类; 图 6a
碧迪BD CD247抗体(BD Biosciences, 558489)被用于被用于免疫细胞化学在人类样本上 (图 6a). Mol Biol Cell (2016) ncbi
小鼠 单克隆(K25-407.69)
  • 免疫细胞化学; 小鼠; 图 6
  • 免疫细胞化学; 人类; 图 3
碧迪BD CD247抗体(BD Biosciences, 558489)被用于被用于免疫细胞化学在小鼠样本上 (图 6) 和 被用于免疫细胞化学在人类样本上 (图 3). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆(K25-407.69)
  • 其他; 人类; 图 st1
碧迪BD CD247抗体(BD, K25-407.69)被用于被用于其他在人类样本上 (图 st1). Mol Cell Proteomics (2016) ncbi
小鼠 单克隆(K25-407.69)
  • 免疫印迹; 小鼠
碧迪BD CD247抗体(BD Biosciences, K25-407.69)被用于被用于免疫印迹在小鼠样本上. PLoS ONE (2014) ncbi
ATCC
小鼠 单克隆
  • 流式细胞仪; 人类; 1 ug/ml; 图 1
ATCC CD247抗体(ATCC, CRL-8001)被用于被用于流式细胞仪在人类样本上浓度为1 ug/ml (图 1). Oncoimmunology (2016) ncbi
文章列表
  1. Choi J, Lee E, Kim S, Park S, Oh S, Kang J, et al. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer. BMC Cancer. 2019;19:817 pubmed 出版商
  2. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed 出版商
  3. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed 出版商
  4. Escolano A, Gristick H, Abernathy M, Merkenschlager J, Gautam R, Oliveira T, et al. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature. 2019;: pubmed 出版商
  5. Zumaquero E, Stone S, Scharer C, Jenks S, Nellore A, Mousseau B, et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. elife. 2019;8: pubmed 出版商
  6. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed 出版商
  7. Collins P, Cella M, Porter S, Li S, Gurewitz G, Hong H, et al. Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells. Cell. 2019;176:348-360.e12 pubmed 出版商
  8. Scheper W, Kelderman S, Fanchi L, Linnemann C, Bendle G, de Rooij M, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25:89-94 pubmed 出版商
  9. Kim H, Mun Y, Lee K, Park Y, Park J, Park J, et al. T cell microvilli constitute immunological synaptosomes that carry messages to antigen-presenting cells. Nat Commun. 2018;9:3630 pubmed 出版商
  10. Young M, Mitchell T, Vieira Braga F, Tran M, Stewart B, Ferdinand J, et al. Single-cell transcriptomes from human kidneys reveal the cellular identity of renal tumors. Science. 2018;361:594-599 pubmed 出版商
  11. Pulikkan J, Hegde M, Ahmad H, Belaghzal H, Illendula A, Yu J, et al. CBFβ-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia. Cell. 2018;174:172-186.e21 pubmed 出版商
  12. Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, et al. CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers. Sci Immunol. 2018;3: pubmed 出版商
  13. Flores Villanueva P, Ganachari M, Guio H, Mejia J, Granados J. An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines. J Immunol. 2018;200:2965-2977 pubmed 出版商
  14. Pizzolla A, Nguyen T, Sant S, Jaffar J, Loudovaris T, Mannering S, et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J Clin Invest. 2018;128:721-733 pubmed 出版商
  15. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed 出版商
  16. Chan Y, Zuo J, Inman C, Croft W, Begum J, Croudace J, et al. NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHD. Eur J Immunol. 2018;48:316-329 pubmed 出版商
  17. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed 出版商
  18. Kruglova N, Meshkova T, Kopylov A, Mazurov D, Filatov A. Constitutive and activation-dependent phosphorylation of lymphocyte phosphatase-associated phosphoprotein (LPAP). PLoS ONE. 2017;12:e0182468 pubmed 出版商
  19. Jiang X, Björkström N, Melum E. Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation. Front Immunol. 2017;8:765 pubmed 出版商
  20. Li L, Guo X, Shi X, Li C, Wu W, Yan C, et al. Ionic CD3-Lck interaction regulates the initiation of T-cell receptor signaling. Proc Natl Acad Sci U S A. 2017;114:E5891-E5899 pubmed 出版商
  21. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed 出版商
  22. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed 出版商
  23. Van Caeneghem Y, De Munter S, Tieppo P, Goetgeluk G, Weening K, Verstichel G, et al. Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities. Oncoimmunology. 2017;6:e1283460 pubmed 出版商
  24. Khodadoust M, Olsson N, Wagar L, Haabeth O, Chen B, Swaminathan K, et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature. 2017;543:723-727 pubmed 出版商
  25. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed 出版商
  26. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed 出版商
  27. Hui E, Cheung J, Zhu J, Su X, Taylor M, Wallweber H, et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science. 2017;355:1428-1433 pubmed 出版商
  28. Szabo P, Goswami A, Mazzuca D, Kim K, O Gorman D, Hess D, et al. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology. J Immunol. 2017;198:2805-2818 pubmed 出版商
  29. Su S, Zou Z, Chen F, Ding N, Du J, Shao J, et al. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer. Oncoimmunology. 2017;6:e1249558 pubmed 出版商
  30. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed 出版商
  31. Kim J, Kwon C, Joh J, Sinn D, Choi G, Park J, et al. Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients. Med Princ Pract. 2017;26:221-228 pubmed 出版商
  32. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed 出版商
  33. Ryan P, Sumaria N, Holland C, Bradford C, Izotova N, Grandjean C, et al. Heterogeneous yet stable Vδ2(+) T-cell profiles define distinct cytotoxic effector potentials in healthy human individuals. Proc Natl Acad Sci U S A. 2016;113:14378-14383 pubmed
  34. Villanueva Cabello T, Martinez Duncker I. Preparation of CD4+ T Cells for Analysis of GD3 and GD2 Ganglioside Membrane Expression by Microscopy. J Vis Exp. 2016;: pubmed 出版商
  35. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed 出版商
  36. Ribeiro S, Tesio M, Ribot J, Macintyre E, Barata J, Silva Santos B. Casein kinase 2 controls the survival of normal thymic and leukemic ?? T cells via promotion of AKT signaling. Leukemia. 2017;31:1603-1610 pubmed 出版商
  37. Cuff A, Robertson F, Stegmann K, Pallett L, Maini M, Davidson B, et al. Eomeshi NK Cells in Human Liver Are Long-Lived and Do Not Recirculate but Can Be Replenished from the Circulation. J Immunol. 2016;197:4283-4291 pubmed
  38. Yi J, Manna A, Barr V, Hong J, Neuman K, Samelson L. madSTORM: a superresolution technique for large-scale multiplexing at single-molecule accuracy. Mol Biol Cell. 2016;27:3591-3600 pubmed
  39. Ishikawa E, Kosako H, Yasuda T, Ohmuraya M, Araki K, Kurosaki T, et al. Protein kinase D regulates positive selection of CD4+ thymocytes through phosphorylation of SHP-1. Nat Commun. 2016;7:12756 pubmed 出版商
  40. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  41. Guillou L, Babataheri A, Saitakis M, Bohineust A, Dogniaux S, Hivroz C, et al. T-lymphocyte passive deformation is controlled by unfolding of membrane surface reservoirs. Mol Biol Cell. 2016;27:3574-3582 pubmed
  42. Pageon S, Nicovich P, Mollazade M, Tabarin T, Gaus K. Clus-DoC: a combined cluster detection and colocalization analysis for single-molecule localization microscopy data. Mol Biol Cell. 2016;27:3627-3636 pubmed
  43. Pageon S, Tabarin T, Yamamoto Y, Ma Y, Nicovich P, Bridgeman J, et al. Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination. Proc Natl Acad Sci U S A. 2016;113:E5454-63 pubmed 出版商
  44. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed 出版商
  45. Miyan M, Schmidt Mende J, Kiessling R, Poschke I, de Boniface J. Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer. J Transl Med. 2016;14:227 pubmed 出版商
  46. Sullivan K, Lewis H, Hill A, Pandey A, Jackson L, Cabral J, et al. Trisomy 21 consistently activates the interferon response. elife. 2016;5: pubmed 出版商
  47. Sadallah S, Schmied L, Eken C, Charoudeh H, Amicarella F, Schifferli J. Platelet-Derived Ectosomes Reduce NK Cell Function. J Immunol. 2016;197:1663-71 pubmed 出版商
  48. Kang J, Park S, Jeong S, Han M, Lee C, Lee K, et al. Epigenetic regulation of Kcna3-encoding Kv1.3 potassium channel by cereblon contributes to regulation of CD4+ T-cell activation. Proc Natl Acad Sci U S A. 2016;113:8771-6 pubmed 出版商
  49. Piepenbrink M, Samuel M, Zheng B, Carter B, Fucile C, Bunce C, et al. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users. PLoS ONE. 2016;11:e0158641 pubmed 出版商
  50. Mo A, Jackson S, Varma K, Carpino A, Giardina C, Devers T, et al. Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development. Mol Cancer Res. 2016;14:795-804 pubmed 出版商
  51. Hahn S, Neuhoff A, Landsberg J, Schupp J, Eberts D, Leukel P, et al. A key role of GARP in the immune suppressive tumor microenvironment. Oncotarget. 2016;7:42996-43009 pubmed 出版商
  52. Yin W, Tong S, Zhang Q, Shao J, Liu Q, Peng H, et al. Functional dichotomy of Vδ2 γδ T cells in chronic hepatitis C virus infections: role in cytotoxicity but not for IFN-γ production. Sci Rep. 2016;6:26296 pubmed 出版商
  53. Kay A, Strauss Albee D, Blish C. Application of Mass Cytometry (CyTOF) for Functional and Phenotypic Analysis of Natural Killer Cells. Methods Mol Biol. 2016;1441:13-26 pubmed 出版商
  54. Siddiqui I, Erreni M, van Brakel M, Debets R, Allavena P. Enhanced recruitment of genetically modified CX3CR1-positive human T cells into Fractalkine/CX3CL1 expressing tumors: importance of the chemokine gradient. J Immunother Cancer. 2016;4:21 pubmed 出版商
  55. Blas Rus N, Bustos Morán E, Perez de Castro I, de Carcer G, Borroto A, Camafeita E, et al. Aurora A drives early signalling and vesicle dynamics during T-cell activation. Nat Commun. 2016;7:11389 pubmed 出版商
  56. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  57. Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, et al. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology. 2016;5:e1048061 pubmed
  58. Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q, et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016;213:399-414 pubmed 出版商
  59. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed 出版商
  60. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed 出版商
  61. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed 出版商
  62. Vivar O, Masi G, Carpier J, Magalhaes J, Galgano D, Pazour G, et al. IFT20 controls LAT recruitment to the immune synapse and T-cell activation in vivo. Proc Natl Acad Sci U S A. 2016;113:386-91 pubmed 出版商
  63. Westman J, Papareddy P, Dahlgren M, Chakrakodi B, Norrby Teglund A, Smeds E, et al. Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo. PLoS Pathog. 2015;11:e1005319 pubmed 出版商
  64. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed 出版商
  65. Miles B, Miller S, Folkvord J, Kimball A, Chamanian M, Meditz A, et al. Follicular regulatory T cells impair follicular T helper cells in HIV and SIV infection. Nat Commun. 2015;6:8608 pubmed 出版商
  66. Venkatasubramanian S, Tripathi D, Tucker T, Paidipally P, Cheekatla S, Welch E, et al. Tissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection. Eur J Immunol. 2016;46:464-79 pubmed 出版商
  67. Spiesberger K, Paulfranz F, Egger A, Reiser J, Vogl C, Rudolf Scholik J, et al. Large-Scale Purification of r28M: A Bispecific scFv Antibody Targeting Human Melanoma Produced in Transgenic Cattle. PLoS ONE. 2015;10:e0140471 pubmed 出版商
  68. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed 出版商
  69. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed 出版商
  70. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed 出版商
  71. Silacci M, Lembke W, Woods R, Attinger Toller I, Baenziger Tobler N, Batey S, et al. Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases. MAbs. 2016;8:141-9 pubmed 出版商
  72. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed 出版商
  73. Nakatsukasa H, Zhang D, Maruyama T, Chen H, Cui K, Ishikawa M, et al. The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells. Nat Immunol. 2015;16:1077-84 pubmed 出版商
  74. Japp A, Kursunel M, Meier S, Mälzer J, Li X, Rahman N, et al. Dysfunction of PSA-specific CD8+ T cells in prostate cancer patients correlates with CD38 and Tim-3 expression. Cancer Immunol Immunother. 2015;64:1487-94 pubmed 出版商
  75. Klammt C, Novotná L, Li D, Wolf M, Blount A, Zhang K, et al. T cell receptor dwell times control the kinase activity of Zap70. Nat Immunol. 2015;16:961-9 pubmed 出版商
  76. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed 出版商
  77. Owens G, Erickson K, Malone C, Pan C, Huynh M, Chang J, et al. Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis. J Neuroinflammation. 2015;12:134 pubmed 出版商
  78. Wang Y, Zhong H, Xie X, Chen C, Huang D, Shen L, et al. Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection. Proc Natl Acad Sci U S A. 2015;112:E3883-92 pubmed 出版商
  79. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed 出版商
  80. Moulton V, Gillooly A, Perl M, Markopoulou A, Tsokos G. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells. PLoS ONE. 2015;10:e0131073 pubmed 出版商
  81. Kim S, Theunissen J, Balibalos J, Liao Chan S, Babcock M, Wong T, et al. A novel antibody-drug conjugate targeting SAIL for the treatment of hematologic malignancies. Blood Cancer J. 2015;5:e316 pubmed 出版商
  82. Tsai P, Chang Y, Lee Y, Ko Y, Yang Y, Lin C, et al. Differentiation of blood T cells: Reprogramming human induced pluripotent stem cells into neuronal cells. J Chin Med Assoc. 2015;78:353-9 pubmed 出版商
  83. Schmueck Henneresse M, Sharaf R, Vogt K, Weist B, Landwehr Kenzel S, Fuehrer H, et al. Peripheral blood-derived virus-specific memory stem T cells mature to functional effector memory subsets with self-renewal potency. J Immunol. 2015;194:5559-67 pubmed 出版商
  84. Anandasabapathy N, Breton G, Hurley A, Caskey M, Trumpfheller C, Sarma P, et al. Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers. Bone Marrow Transplant. 2015;50:924-30 pubmed 出版商
  85. Zhou J, Amran F, Kramski M, Angelovich T, Elliott J, Hearps A, et al. An NK Cell Population Lacking FcRγ Is Expanded in Chronically Infected HIV Patients. J Immunol. 2015;194:4688-97 pubmed 出版商
  86. Vassena L, Giuliani E, Koppensteiner H, Bolduan S, Schindler M, Doria M. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes. J Virol. 2015;89:5687-700 pubmed 出版商
  87. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed 出版商
  88. Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D, et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900 pubmed 出版商
  89. Claiborne D, Prince J, Scully E, Macharia G, Micci L, Lawson B, et al. Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression. Proc Natl Acad Sci U S A. 2015;112:E1480-9 pubmed 出版商
  90. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed 出版商
  91. Comrie W, Babich A, Burkhardt J. F-actin flow drives affinity maturation and spatial organization of LFA-1 at the immunological synapse. J Cell Biol. 2015;208:475-91 pubmed 出版商
  92. Chauhan A, Chen C, Moore T, DiPaolo R. Induced expression of FcγRIIIa (CD16a) on CD4+ T cells triggers generation of IFN-γhigh subset. J Biol Chem. 2015;290:5127-40 pubmed 出版商
  93. Ito S, Barrett A, Dutra A, Pak E, Miner S, Keyvanfar K, et al. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells. Stem Cell Res. 2015;14:95-104 pubmed 出版商
  94. Caramalho I, Nunes Silva V, Pires A, Mota C, Pinto A, Nunes Cabaço H, et al. Human regulatory T-cell development is dictated by Interleukin-2 and -15 expressed in a non-overlapping pattern in the thymus. J Autoimmun. 2015;56:98-110 pubmed 出版商
  95. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed 出版商
  96. Chovancová J, Bernard T, Stehlíková O, Sálek D, Janíková A, Mayer J, et al. Detection of Minimal Residual Disease in Mantle Cell Lymphoma. Establishment of Novel 8-Color Flow Cytometry Approach. Cytometry B Clin Cytom. 2014;: pubmed 出版商
  97. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed 出版商
  98. Freeman A, Bridge J, Maruthayanar P, Overgaard N, Jung J, Simpson F, et al. Comparative immune phenotypic analysis of cutaneous Squamous Cell Carcinoma and Intraepidermal Carcinoma in immune-competent individuals: proportional representation of CD8+ T-cells but not FoxP3+ Regulatory T-cells is associated with disease stage. PLoS ONE. 2014;9:e110928 pubmed 出版商
  99. Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L, et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75 pubmed 出版商
  100. Gerna G, Lilleri D, Fornara C, Bruno F, Gabanti E, Cane I, et al. Differential kinetics of human cytomegalovirus load and antibody responses in primary infection of the immunocompetent and immunocompromised host. J Gen Virol. 2015;96:360-9 pubmed 出版商
  101. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed 出版商
  102. Cucak H, Vistisen D, Witte D, Philipsen A, Rosendahl A. Reduction of specific circulating lymphocyte populations with metabolic risk factors in patients at risk to develop type 2 diabetes. PLoS ONE. 2014;9:e107140 pubmed 出版商
  103. Abramowski P, Ogrodowczyk C, Martin R, Pongs O. A truncation variant of the cation channel P2RX5 is upregulated during T cell activation. PLoS ONE. 2014;9:e104692 pubmed 出版商
  104. Ramirez L, Arango T, Thompson E, Naji M, Tebas P, Boyer J. High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART. J Leukoc Biol. 2014;96:1055-63 pubmed 出版商
  105. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed 出版商
  106. Ohue Y, Kurose K, Mizote Y, Matsumoto H, Nishio Y, Isobe M, et al. Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody. Clin Cancer Res. 2014;20:5052-63 pubmed 出版商
  107. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed 出版商
  108. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed 出版商
  109. Butcher L, Garcia M, Arnold M, Ueno H, Goel A, Boland C. Immune response to JC virus T antigen in patients with and without colorectal neoplasia. Gut Microbes. 2014;5:468-75 pubmed 出版商
  110. Fujisawa D, Kashiwakura J, Kita H, Kikukawa Y, Fujitani Y, Sasaki Sakamoto T, et al. Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. J Allergy Clin Immunol. 2014;134:622-633.e9 pubmed 出版商
  111. Kaczmarek J, Homsi Y, van Üüm J, Metzger C, Knolle P, Kolanus W, et al. Liver sinusoidal endothelial cell-mediated CD8 T cell priming depends on co-inhibitory signal integration over time. PLoS ONE. 2014;9:e99574 pubmed 出版商
  112. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed 出版商
  113. Barbosa R, Silva S, Silva S, Melo A, Pereira Santos M, Barata J, et al. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency. J Clin Immunol. 2014;34:573-83 pubmed 出版商
  114. Tarbox J, Keppel M, Topcagic N, Mackin C, Ben Abdallah M, Baszis K, et al. Elevated double negative T cells in pediatric autoimmunity. J Clin Immunol. 2014;34:594-9 pubmed 出版商
  115. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed 出版商
  116. Ye W, Xing Y, Paustian C, van de Ven R, Moudgil T, Hilton T, et al. Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory T cells. J Transl Med. 2014;12:100 pubmed 出版商
  117. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed 出版商
  118. Abramowski P, Otto B, Martin R. The orally available, synthetic ether lipid edelfosine inhibits T cell proliferation and induces a type I interferon response. PLoS ONE. 2014;9:e91970 pubmed 出版商
  119. Le Saout C, Hasley R, Imamichi H, Tcheung L, Hu Z, Luckey M, et al. Chronic exposure to type-I IFN under lymphopenic conditions alters CD4 T cell homeostasis. PLoS Pathog. 2014;10:e1003976 pubmed 出版商
  120. Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15:354-364 pubmed 出版商
  121. Lyngaa R, Pedersen N, Schrama D, Thrue C, Ibrani D, Met O, et al. T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors. Clin Cancer Res. 2014;20:1768-78 pubmed 出版商
  122. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed 出版商
  123. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed 出版商
  124. Yang C, Li J, Chiu L, Lan J, Chen D, Chuang H, et al. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation. J Immunol. 2014;192:1547-57 pubmed 出版商
  125. Rodriguez M, Loyd C, Ding X, Karim A, MCDONALD D, Canaday D, et al. Mycobacterial phosphatidylinositol mannoside 6 (PIM6) up-regulates TCR-triggered HIV-1 replication in CD4+ T cells. PLoS ONE. 2013;8:e80938 pubmed 出版商
  126. Rapetti L, Chavele K, Evans C, Ehrenstein M. B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. Ann Rheum Dis. 2015;74:294-302 pubmed 出版商
  127. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed 出版商
  128. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed 出版商
  129. Didigu C, Wilen C, Wang J, Duong J, Secreto A, Danet Desnoyers G, et al. Simultaneous zinc-finger nuclease editing of the HIV coreceptors ccr5 and cxcr4 protects CD4+ T cells from HIV-1 infection. Blood. 2014;123:61-9 pubmed 出版商
  130. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed 出版商
  131. Melis L, Van Praet L, Pircher H, Venken K, Elewaut D. Senescence marker killer cell lectin-like receptor G1 (KLRG1) contributes to TNF-? production by interaction with its soluble E-cadherin ligand in chronically inflamed joints. Ann Rheum Dis. 2014;73:1223-31 pubmed 出版商
  132. Introini A, Vanpouille C, Lisco A, Grivel J, Margolis L. Interleukin-7 facilitates HIV-1 transmission to cervico-vaginal tissue ex vivo. PLoS Pathog. 2013;9:e1003148 pubmed 出版商
  133. Frahm M, Picking R, Kuruc J, McGee K, Gay C, Eron J, et al. CD4+CD8+ T cells represent a significant portion of the anti-HIV T cell response to acute HIV infection. J Immunol. 2012;188:4289-96 pubmed 出版商
  134. Meeths M, Chiang S, Wood S, Entesarian M, Schlums H, Bang B, et al. Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D. Blood. 2011;118:5783-93 pubmed 出版商
  135. Magrini E, Szabo I, Doni A, Cibella J, Viola A. Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12. PLoS ONE. 2011;6:e22482 pubmed 出版商
  136. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed 出版商
  137. Correia M, Costa A, Uhrberg M, Cardoso E, Arosa F. IL-15 induces CD8+ T cells to acquire functional NK receptors capable of modulating cytotoxicity and cytokine secretion. Immunobiology. 2011;216:604-12 pubmed 出版商
  138. Markley J, Sadelain M. IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood. 2010;115:3508-19 pubmed 出版商
  139. Oo Y, Weston C, Lalor P, Curbishley S, Withers D, Reynolds G, et al. Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver. J Immunol. 2010;184:2886-98 pubmed 出版商
  140. Kapoor V, Hakim F, Rehman N, Gress R, Telford W. Quantum dots thermal stability improves simultaneous phenotype-specific telomere length measurement by FISH-flow cytometry. J Immunol Methods. 2009;344:6-14 pubmed 出版商
  141. Karagoz B, Bilgi O, Gumus M, Erikci A, Sayan O, Turken O, et al. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Med Oncol. 2010;27:29-33 pubmed 出版商
  142. Richardson M, Carroll R, Stremlau M, Korokhov N, Humeau L, Silvestri G, et al. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol. 2008;82:11117-28 pubmed 出版商
  143. Kueng H, Leb V, Haiderer D, Raposo G, Thery C, Derdak S, et al. General strategy for decoration of enveloped viruses with functionally active lipid-modified cytokines. J Virol. 2007;81:8666-76 pubmed
  144. Clarke S, Betts G, Plant A, Wright K, El Shanawany T, Harrop R, et al. CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer. PLoS ONE. 2006;1:e129 pubmed
  145. Xin K, Mizukami H, Urabe M, Toda Y, Shinoda K, Yoshida A, et al. Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells. J Virol. 2006;80:11899-910 pubmed
  146. Hoves S, Krause S, Schutz C, Halbritter D, Scholmerich J, Herfarth H, et al. Monocyte-derived human macrophages mediate anergy in allogeneic T cells and induce regulatory T cells. J Immunol. 2006;177:2691-8 pubmed
  147. Quiroga M, Pasquinelli V, Martinez G, Jurado J, Zorrilla L, Musella R, et al. Inducible costimulator: a modulator of IFN-gamma production in human tuberculosis. J Immunol. 2006;176:5965-74 pubmed
  148. Loza M, Perussia B. Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine production. J Immunol. 2002;169:3061-8 pubmed
  149. Borst J, Alexander S, Elder J, Terhorst C. The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. J Biol Chem. 1983;258:5135-41 pubmed
  150. Gold D, Puck J, Pettey C, Cho M, Coligan J, Woody J, et al. Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex. Nature. 1986;321:431-4 pubmed